Effect of Nonsurgical Periodontal Therapy On IL-36 Levels in Serum, Gingival Crevicular Fluid of Type 2 Diabetic and Non-Diabetic Patients with Chronic Periodontitis
Open Access
- 11 January 2022
- journal article
- Published by Faculty of Dentistry Khalij-Libya Dental College in Khalij-Libya Journal of Dental and Medical Research
- Vol. 6 (1), 31-34
- https://doi.org/10.47705/kjdmr.216106
Abstract
Objective: The aim of this study was to compare the level of inflammatory marker IL-36β in serum and gingival crevicular fluid in type 2 diabetic and non-diabetic patients with chronic periodontitis, before and after phase I therapy. Methods: A total of fifty subjects was included in this study; 20 Type 2 diabetic subjects with chronic periodontitis (group I) and 20 systemically healthy subjects with chronic periodontitis (group II) in addition to 10 systemically healthy subjects with clinically healthy gingiva as a control group (group III). The nonsurgical periodontal therapy was done to both group I and group II. Periodontal parameters, including plaque index, gingival index, bleeding on probing, probing depth and the clinical attachment level, in all the sites were recorded. GCF and serum were collected from all individuals included in the study; the first sample was collected from all groups (study and control) before phase I therapy. The second sample was collected 6 weeks after phase I therapy from group I& group II. Levels of IL-36β in GCF and serum were quantified using ELISA. Results. The current results showed statistically significant reduction in total level of IL-36β in serum and GCF in both groups; Type 2 diabetes with chronic periodontitis group (I) and systemically healthy with periodontitis group (II) after phase I therapy. Results also showed all clinical parameters were significantly improved after the phase I periodontal therapy in both groups I &II (p<0.001). Conclusions. Scaling and root planning (SRP) is the mainstay of treatment of periodontal diseases as SRP was effective in improving clinical parameters in diabetic and non-diabetic patients with chronic periodontitis. IL-36β could be used as a potential diagnostic marker for periodontal disease activity in both serum and gingival crevicular fluid.Keywords
This publication has 6 references indexed in Scilit:
- Serum leveis of inflammatory markers in type 2 diabetes patients with chronic periodontitisJournal of Applied Oral Science, 2014
- Effects of Scaling and Root Planing and Subantimicrobial Dose Doxycycline on Gingival Crevicular Fluid Levels of Matrix Metalloproteinase‐8, ‐13 and Serum Levels of HsCRP in Patients With Chronic PeriodontitisThe Journal of Periodontology, 2010
- Adipokines and Inflammatory Mediators After Initial Periodontal Treatment in Patients With Type 2 Diabetes and Chronic PeriodontitisThe Journal of Periodontology, 2010
- Inhibition of Experimental Periodontitis by a Topical Boron-based AntimicrobialJournal of Dental Research, 2008
- IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- Interleukin‐1β, tumor necrosis factor‐α levels and neutrophil elastase activity in peri‐implant crevicular fluidClinical Oral Implants Research, 2002